Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Reference: Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society Mozaffarian, Dariush et al
For broader treatment placement in type 2 diabetes, see Injectable Type 2 Diabetes for context on when GLP-1 RAs complement other classes
The first compared GLP-1 receptor agonist users with nonusers among patients with obesity but without type 2 diabetes
If you choose nasal spray despite these limitations, use approximately 1.0-1.5 mg per application (equivalent to 0.5 mg injected)
US$ 26.13
US$ 24.25
US$ 20.98
US$ 29.71
US$ 26.22
US$ 23.71
